Drug intelligence / Profile preview

Tussi-Planta

Development stage: Unknown
Lead developer: ORENDA
Administration: Oral

Overview

Tussi-Planta is an herbal medicinal product developed by ORENDA, primarily indicated as a cough sedative and expectorant. It is typically formulated as a syrup containing extracts of *Thymus vulgaris* (Thyme) and *Hedera helix* (Ivy leaf). These botanical components work synergistically to provide mucolytic, secretolytic, and bronchospasmolytic effects. Thyme extract is known for its antimicrobial and antitussive properties, while Ivy leaf extract contains saponins, such as alpha-hederin, that facilitate the thinning of mucus and ease its expulsion by modulating airway resistance through the stabilization of beta-2 adrenergic receptors. It is used for the symptomatic treatment of acute and chronic inflammatory bronchial diseases.

Brand names: Tussi-Planta
Other names: Tussi Planta Syrup

Targets

ADRB2 (β2)

Beyond the preview

Go deeper on Tussi-Planta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tussi-Planta.

Explore the full profile